Historical Valuation
Tevogen Bio Holdings Inc (TVGN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -0.93. The fair price of Tevogen Bio Holdings Inc (TVGN) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.39
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Tevogen Bio Holdings Inc (TVGN) has a current Price-to-Book (P/B) ratio of -4.32. Compared to its 3-year average P/B ratio of -10.68 , the current P/B ratio is approximately -59.53% higher. Relative to its 5-year average P/B ratio of -11.67, the current P/B ratio is about -62.98% higher. Tevogen Bio Holdings Inc (TVGN) has a Forward Free Cash Flow (FCF) yield of approximately -18.25%. Compared to its 3-year average FCF yield of -7.07%, the current FCF yield is approximately 158.22% lower. Relative to its 5-year average FCF yield of -7.07% , the current FCF yield is about 158.22% lower.
P/B
Median3y
-10.68
Median5y
-11.67
FCF Yield
Median3y
-7.07
Median5y
-7.07
Competitors Valuation Multiple
AI Analysis for TVGN
The average P/S ratio for TVGN competitors is 222.57, providing a benchmark for relative valuation. Tevogen Bio Holdings Inc Corp (TVGN.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for TVGN
1Y
3Y
5Y
Market capitalization of TVGN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of TVGN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is TVGN currently overvalued or undervalued?
Tevogen Bio Holdings Inc (TVGN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -0.93. The fair price of Tevogen Bio Holdings Inc (TVGN) is between to according to relative valuation methord.
What is Tevogen Bio Holdings Inc (TVGN) fair value?
TVGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Tevogen Bio Holdings Inc (TVGN) is between to according to relative valuation methord.
How does TVGN's valuation metrics compare to the industry average?
The average P/S ratio for TVGN's competitors is 222.57, providing a benchmark for relative valuation. Tevogen Bio Holdings Inc Corp (TVGN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Tevogen Bio Holdings Inc (TVGN) as of Jan 09 2026?
As of Jan 09 2026, Tevogen Bio Holdings Inc (TVGN) has a P/B ratio of -4.32. This indicates that the market values TVGN at -4.32 times its book value.
What is the current FCF Yield for Tevogen Bio Holdings Inc (TVGN) as of Jan 09 2026?
As of Jan 09 2026, Tevogen Bio Holdings Inc (TVGN) has a FCF Yield of -18.25%. This means that for every dollar of Tevogen Bio Holdings Inc’s market capitalization, the company generates -18.25 cents in free cash flow.
What is the current Forward P/E ratio for Tevogen Bio Holdings Inc (TVGN) as of Jan 09 2026?
As of Jan 09 2026, Tevogen Bio Holdings Inc (TVGN) has a Forward P/E ratio of -1.80. This means the market is willing to pay $-1.80 for every dollar of Tevogen Bio Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Tevogen Bio Holdings Inc (TVGN) as of Jan 09 2026?
As of Jan 09 2026, Tevogen Bio Holdings Inc (TVGN) has a Forward P/S ratio of 0.00. This means the market is valuing TVGN at $0.00 for every dollar of expected revenue over the next 12 months.